Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H25NO2.ClH |
Molecular Weight | 311.847 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(=O)O[C@]1(C[C@H](C)N(C)C[C@H]1C)C2=CC=CC=C2
InChI
InChIKey=USGVEUCDHRWIRO-RECIXLKMSA-N
InChI=1S/C17H25NO2.ClH/c1-5-16(19)20-17(15-9-7-6-8-10-15)11-14(3)18(4)12-13(17)2;/h6-10,13-14H,5,11-12H2,1-4H3;1H/t13-,14+,17+;/m1./s1
Trimeperidine (promedol) is the earliest and mostly studied opioid analgesic. Trimeperidine stimulates opioid receptors in the central nervous system. Compared with morphine, it has a weaker and shorter analgesic effect, less affects the respiratory, vomiting and vagal centers, does not cause smooth muscle spasm (except for the myometrium), and has a moderate antispasmodic and hypnotic effect. It is used to treat severe pain syndrome, acute left ventricular failure, pulmonary edema, cardiogenic shock, preparation for surgery, childbirth, high fever, post-transfusion complications, poisoning with atropine, barbiturates, barium, gasoline, boric acid, strong acids, carbon monoxide, turpentine, formalin, formalin. It has several side effects. Administration of this substance is associated with the development of life-threatening conditions accompanied by the suppression of respiration center. Analgesic trimeperidine (promedol) was included into the health care kits by various Ministries of the Russian Federation at different times.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Characteristics of anesthesia in children operated on for extrahepatic portal hypertension]. | 2001 Jan-Feb |
|
[Efficacy and safety of lornoxicam in an early postoperative period]. | 2007 |
|
[Factors predisposing to acute urine retention in patients with prostatic adenoma]. | 2007 Mar-Apr |
|
[Comparison of analgesics using two devices for the patient-controlled analgesia]. | 2009 Jul-Aug |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90924988
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
21117286
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
U3696V8BXT
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
SUB04968MIG
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
42325-78-0
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY | |||
|
125-80-4
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
100000084645
Created by
admin on Sat Dec 16 04:40:41 GMT 2023 , Edited by admin on Sat Dec 16 04:40:41 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD